Bis-Rnai Trademark Details

This mark is alive with a status of Published for Opposition. The last case file activity for this mark occured 7 years ago on Tuesday, September 27, 2016, according to the United State Patent & Trademark Office
Word Mark Bis-Rnai
Status Alive 686 — Published for Opposition

Current Owner

Alnylam Pharmaceuticals Inc of Cambridge, MA

View all trademarks for Alnylam Pharmaceuticals Inc
Other Trademarks for Alnylam Pharmaceuticals Inc
Serial Number 86778596
Status Date Tuesday, September 27, 2016
Filing Date Tuesday, September 27, 2016
Attorney Ann Lamport Hammitte

Correspondent

ANN LAMPORT HAMMITTE
LANDO & ANASTASI, LLP
ONE MAIN STREET
CAMBRIDGE, MA 02142

Case File Statements

Goods & Services pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection
Pseudo Mark Bis Rnai; Bis Rna Interference; Bis Ribonucleic Acid Interference

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, October 8, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.